Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study

Journal:

The BMJ

Published:

2026-02-04

DOI:

10.1136/bmj-2025-084831

Affiliations:

27

Authors:

32

Go to article

Institutions	Authors	Share
Zhongnan Hospital, WHU, China	8.500000	0.27
Central Hospital of Wuhan, China	3.000000	0.09
Huazhong University of Science and Technology (HUST), China	2.500000	0.08
Tongji Hospital (TJH), HUST, China	2.000000	0.06
The Sixth Affiliated Hospital, SYSU, China	1.000000	0.03
GeneRulor Company Bio-X Lab, China	1.000000	0.03
Huanggang Maternity and Child Health Care Hospital, China	1.000000	0.03
The First People's Hospital of Tianmen, China	1.000000	0.03
Huangmei People’s Hospital, China	1.000000	0.03
Maternal and Child Health Care Hospital of Zhongxiang, China	1.000000	0.03
Zhongxiang People's Hospital, China	1.000000	0.03
Yingshan People's Hospital, China	1.000000	0.03
Wuxue First People's Hospital, China	1.000000	0.03
Huangmei County Maternal and Child Health Hospital, China	1.000000	0.03
Gucheng County People’s Hospital, China	1.000000	0.03
Dawu People’s Hospital, China	1.000000	0.03
Wuhan Union Hospital, HUST, China	1.000000	0.03
Zaoyang Maternity and Child Health Care Hospital, China	1.000000	0.03
Tongji Medical College, HUST, China	0.500000	0.02
The Second People's Hospital of Yichang, China	0.500000	0.02
China Three Gorges University (CTGU), China	0.500000	0.02
Wuhan University (WHU), China	0.500000	0.02

Interested in Epidemiology?